• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羧基功能化介孔硅纳米粒子用于控制递释难溶性非甾体抗炎药物。

Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.

机构信息

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD103, Shenyang, Liaoning 110016, China.

School of Pharmacy, China Medical University, Puhe RD77, Shenyang North New Area, Shenyang, Liaoning 110122, China.

出版信息

Acta Biomater. 2021 Oct 15;134:576-592. doi: 10.1016/j.actbio.2021.07.023. Epub 2021 Jul 17.

DOI:10.1016/j.actbio.2021.07.023
PMID:34280558
Abstract

The purpose of this study was to investigate the delivery of poorly water-soluble non-steroidal anti-inflammatory drugs (NSAIDs) by carboxyl-functionalized mesoporous silica nanoparticles (MSN-COOH) with high specific surface area (S). In this study, MSN-COOH was prepared by collaborative self-assembly using cetyltrimethylammonium bromide (CTAB) as template and hydrolysis (3-triethoxyl-propyl) succinic anhydride (TESPSA) as co-structure auxiliary directing agent (CSDA). The drug delivery systems were constructed with NSAIDs including Nimesulide (NMS) and Indomethacin (IMC) as model drugs. Moreover, the characterization techniques, hemolysis and bio-adsorption testes, in vitro drug release and in vivo biological studies of MSN-COOH were also carried out. The characterization results showed that MSN-COOH is spheres with clearly visible irregular honeycomb nanopores and rough surface (S: 1257 m/g, pore volume (V): 1.17 cm/g). After loading NMS/IMC into MSN-COOH with high drug loading efficiency (NMS: 98.7 and IMC: 98.2%), most crystalline NMS and IMC converted to amorphous phase confirmed using differential scanning calorimeter (DSC) and X-ray power diffraction (XRD) analysis. Meanwhile, MSN-COOH significantly increased the dissolution of NMS and IMC compared with non-functionalized mesoporous silica nanoparticles (MSN), which was also confirmed by wettability experiments. The results of in vivo biological effects showed that MSN-COOH had higher bioavailability of NMS and IMC than MSN, and exerted strong anti-inflammatory effects by delivering more NMS and IMC in vivo. STATEMENT OF SIGNIFICANCE: This study successfully prepared MSNs-COOH (mesoporous silica nanoparticles modified with negatively charged carboxyl groups on the surface and in the pores) with high specific surface area and pore volume by using the negatively charged carboxyl group (hyd-TESPSA) and the positively charged CTAB self-assembled through electrostatic attraction under alkaline conditions. The drug delivery systems were constructed with Nimesulide (NMS) and Indomethacin (IMC) as model drugs. The results showed MSNs-COOH had high drug loading capacity and also exhibited good in vitro drug release properties. Interestingly, NMS loaded MSNs-COOH also had a potential pH responsive release effect. In vivo biological studies revealed that NMS/IMC loaded MSNs-COOH could evidently improve the bioavailability and played the strong anti-inflammatory effects.

摘要

这项研究的目的是探讨通过具有高比表面积 (S) 的羧基功能化介孔硅纳米粒子 (MSN-COOH) 递运疏水性非甾体抗炎药 (NSAIDs)。在这项研究中,MSN-COOH 是通过使用十六烷基三甲基溴化铵 (CTAB) 作为模板和水解 (3-三乙氧基丙基) 琥珀酸酐 (TESPSA) 作为共结构辅助导向剂 (CSDA) 的协同自组装制备的。药物递送系统由 NSAIDs 构建,包括尼美舒利 (NMS) 和吲哚美辛 (IMC) 作为模型药物。此外,还对 MSN-COOH 的表征技术、溶血和生物吸附试验、体外药物释放和体内生物学研究进行了研究。表征结果表明,MSN-COOH 是具有明显可见不规则蜂窝纳米孔和粗糙表面的球体 (S:1257 m/g,孔体积 (V):1.17 cm/g)。将 NMS/IMC 负载到具有高载药效率的 MSN-COOH 中 (NMS:98.7%和 IMC:98.2%) 后,使用差示扫描量热法 (DSC) 和 X 射线粉末衍射 (XRD) 分析证实,大多数结晶 NMS 和 IMC 转化为非晶相。同时,与非功能化介孔硅纳米粒子 (MSN) 相比,MSN-COOH 显著提高了 NMS 和 IMC 的溶解度,润湿性实验也证实了这一点。体内生物效应的结果表明,MSN-COOH 使 NMS 和 IMC 的生物利用度高于 MSN,并通过在体内传递更多的 NMS 和 IMC 发挥了强大的抗炎作用。研究意义:本研究成功制备了具有高比表面积和孔体积的 MSNs-COOH(表面和孔中带负电荷的羧基修饰的介孔硅纳米粒子),方法是在碱性条件下通过静电吸引使带负电荷的羧基(hyd-TESPSA)和带正电荷的 CTAB 自组装。药物递送系统由尼美舒利 (NMS) 和吲哚美辛 (IMC) 作为模型药物构建。结果表明,MSNs-COOH 具有高载药能力,并且表现出良好的体外药物释放性能。有趣的是,负载 NMS 的 MSNs-COOH 还具有潜在的 pH 响应释放效果。体内生物学研究表明,负载 NMS/IMC 的 MSNs-COOH 可以明显提高生物利用度并发挥强大的抗炎作用。

相似文献

1
Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.羧基功能化介孔硅纳米粒子用于控制递释难溶性非甾体抗炎药物。
Acta Biomater. 2021 Oct 15;134:576-592. doi: 10.1016/j.actbio.2021.07.023. Epub 2021 Jul 17.
2
Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.用于提高难溶性缬沙坦口服生物利用度和抗高血压活性的改性介孔二氧化硅纳米颗粒
Eur J Pharm Sci. 2017 Mar 1;99:152-160. doi: 10.1016/j.ejps.2016.12.015. Epub 2016 Dec 18.
3
Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.新型快速合成中空介孔硅纳米粒子(HMSNs)的方案及其作为改善难溶性 BCS Ⅱ类药物口服生物利用度的有效递送载体的应用。
Colloids Surf B Biointerfaces. 2019 Apr 1;176:185-193. doi: 10.1016/j.colsurfb.2019.01.004. Epub 2019 Jan 2.
4
Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.载氟比洛芬手性介孔硅药物输送系统的 pH 和手性微环境双重响应释放。
Colloids Surf B Biointerfaces. 2021 Mar;199:111501. doi: 10.1016/j.colsurfb.2020.111501. Epub 2020 Dec 4.
5
Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.大孔尺寸手性介孔硅纳米载药粒子展现出优越的药物传递效果。
Molecules. 2019 Sep 30;24(19):3552. doi: 10.3390/molecules24193552.
6
Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.三种介孔硅微球的简易合成及其作为药物载体的缓释性能。
Curr Drug Deliv. 2023;20(9):1337-1350. doi: 10.2174/1567201819666220616121602.
7
A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.介孔碳和介孔硅作为水不溶性药物卡维地洛口服给药载体的比较研究。
Molecules. 2019 May 7;24(9):1770. doi: 10.3390/molecules24091770.
8
Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.氨基酸修饰的手性介孔硅纳米粒子在递送达美辛中的优势。
Artif Cells Nanomed Biotechnol. 2018 Aug;46(5):1085-1094. doi: 10.1080/21691401.2017.1360326. Epub 2017 Aug 4.
9
Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug.用于包载难溶性药物的功能化离子表面活性剂模板介孔二氧化硅的简便合成
Int J Pharm. 2015 Aug 15;492(1-2):191-8. doi: 10.1016/j.ijpharm.2015.07.014. Epub 2015 Jul 8.
10
Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.有序纳米孔硅作为载体提高难溶性药物的递送:三维和二维大孔硅的比较研究。
Int J Nanomedicine. 2013;8:4015-31. doi: 10.2147/IJN.S52605. Epub 2013 Oct 22.

引用本文的文献

1
Surface Functionalization of Nanoparticles for Enhanced Electrostatic Adsorption of Biomolecules.用于增强生物分子静电吸附的纳米颗粒表面功能化
Molecules. 2025 Jul 30;30(15):3206. doi: 10.3390/molecules30153206.
2
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy.介孔二氧化硅纳米颗粒在基因治疗中的最新应用
Adv Healthc Mater. 2025 Feb 10:e2404781. doi: 10.1002/adhm.202404781.
3
Solubilization techniques used for poorly water-soluble drugs.用于难溶性药物的增溶技术。
Acta Pharm Sin B. 2024 Nov;14(11):4683-4716. doi: 10.1016/j.apsb.2024.08.027. Epub 2024 Sep 2.
4
Discovery of Galangin Derivatives as a Potential T-cell Leukemia Virus 1 Protease Inhibitor Through Chemoinformatics Approaches.通过化学信息学方法发现高良姜素衍生物作为潜在的1型T细胞白血病病毒蛋白酶抑制剂
Cell Biochem Biophys. 2025 Jun;83(2):2067-2088. doi: 10.1007/s12013-024-01618-w. Epub 2024 Dec 3.
5
Prenatal Silicon Dioxide Nanoparticles Exposure Reduces Female Offspring Fertility Without Affecting Males.产前暴露于二氧化硅纳米颗粒会降低雌性后代的生育能力,而对雄性后代没有影响。
Adv Sci (Weinh). 2025 Jan;12(3):e2410353. doi: 10.1002/advs.202410353. Epub 2024 Nov 22.
6
Nanotechnology in healthcare, and its safety and environmental risks.纳米技术在医疗保健中的应用,及其安全性和环境风险。
J Nanobiotechnology. 2024 Nov 15;22(1):715. doi: 10.1186/s12951-024-02901-x.
7
Nanoparticle-based approaches for treating restenosis after vascular injury.基于纳米颗粒的血管损伤后再狭窄治疗方法。
Front Pharmacol. 2024 Oct 24;15:1427651. doi: 10.3389/fphar.2024.1427651. eCollection 2024.
8
Evaluation of the synergistic effects of curcumin-resveratrol co-loaded biogenic silica on colorectal cancer cells.姜黄素-白藜芦醇共负载生物源二氧化硅对结肠癌细胞协同作用的评估
Front Pharmacol. 2024 Jun 11;15:1341773. doi: 10.3389/fphar.2024.1341773. eCollection 2024.
9
Effect of Amine, Carboxyl, or Thiol Functionalization of Mesoporous Silica Particles on Their Efficiency as a Quercetin Delivery System in Simulated Gastrointestinal Conditions.介孔二氧化硅颗粒的胺基、羧基或硫醇官能化对其在模拟胃肠道条件下作为槲皮素递送系统的效率的影响。
Foods. 2024 Apr 16;13(8):1208. doi: 10.3390/foods13081208.
10
Conveyance of sofosbuvir through vesicular lipid nanocarriers as an effective strategy for management of viral meningitis.索磷布韦通过囊泡脂质纳米载体的转运作为治疗病毒性脑膜炎的有效策略。
RSC Adv. 2023 Nov 15;13(47):33500-33513. doi: 10.1039/d3ra06540e. eCollection 2023 Nov 7.